{ "source": "Nasdaq Nordic Company News", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "status": "retrieved", "company": "Medivir", "reports": [ { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T05:17:34Z", "company": "Medivir AB", "title": "MEDIVIR AB - DELÅRSRAPPORT JANUARI - MARS 2026", "category": "Interimsrapport", "date": "2026-05-05", "language": "sv", "report_type": "interim-report", "fiscal_year": 2026, "quarter": "q1", "period": "2026-q1", "report_key": "2026:q1", "release_url": "https://view.news.eu.nasdaq.com/view?id=b7ce7beaef524d3a18039e7e30f9a0c54&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2026-q1\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2026-q1\\release.txt", "attachments": [ { "label": "DELARSRAPPORT JANUARI - MARS 2026.pdf", "url": "https://attachment.news.eu.nasdaq.com/a1eac606309a5863337eb11c2784504a1", "final_url": "https://attachment.news.eu.nasdaq.com/a1eac606309a5863337eb11c2784504a1", "filename": "DELARSRAPPORT_JANUARI_-_MARS_2026.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2026-q1\\DELARSRAPPORT_JANUARI_-_MARS_2026.pdf", "content_type": "application/pdf", "size": 393697, "sha256": "c25d7da3b34495fc8ef9d0e7dd964e3d3a75d242c5a1344af90ecd03d51a87e9", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2026-q1\\DELARSRAPPORT_JANUARI_-_MARS_2026.pdf", "filename": "DELARSRAPPORT_JANUARI_-_MARS_2026.pdf", "extension": ".pdf", "size": 393697, "sha256": "c25d7da3b34495fc8ef9d0e7dd964e3d3a75d242c5a1344af90ecd03d51a87e9", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2026-q1\\extracted\\DELARSRAPPORT_JANUARI_-_MARS_2026\\DELARSRAPPORT_JANUARI_-_MARS_2026.txt", "text_chars": 43250, "metadata": { "page_count": 16, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2026-q1\\extracted\\DELARSRAPPORT_JANUARI_-_MARS_2026\\DELARSRAPPORT_JANUARI_-_MARS_2026.extraction.json" } } ], "announcement_id": "1439585", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T05:17:47Z", "company": "Medivir AB", "title": "Medivirs årsredovisning för 2025 publiceras", "category": "Bokslut och Verksamhetsberättelse", "date": "2026-04-01", "language": "sv", "report_type": "annual-report", "fiscal_year": 2025, "quarter": "annual", "period": "2025-annual", "report_key": "2025:annual", "release_url": "https://view.news.eu.nasdaq.com/view?id=b81c7d02dae451f78ae10c56b1b70462f&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2025-annual\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2025-annual\\release.txt", "attachments": [ { "label": "Medivir Arsredovisning 2025.pdf", "url": "https://attachment.news.eu.nasdaq.com/a9bb558555bc85bf7e60c61a0fe19a9c5", "final_url": "https://attachment.news.eu.nasdaq.com/a9bb558555bc85bf7e60c61a0fe19a9c5", "filename": "Medivir_Arsredovisning_2025.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2025-annual\\Medivir_Arsredovisning_2025.pdf", "content_type": "application/pdf", "size": 3534517, "sha256": "e1348bdd761768fca53228aa1a9352c87e679808ce8f8abc114cef70d463de77", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2025-annual\\Medivir_Arsredovisning_2025.pdf", "filename": "Medivir_Arsredovisning_2025.pdf", "extension": ".pdf", "size": 3534517, "sha256": "e1348bdd761768fca53228aa1a9352c87e679808ce8f8abc114cef70d463de77", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2025-annual\\extracted\\Medivir_Arsredovisning_2025\\Medivir_Arsredovisning_2025.txt", "text_chars": 267756, "metadata": { "page_count": 72, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2025-annual\\extracted\\Medivir_Arsredovisning_2025\\Medivir_Arsredovisning_2025.extraction.json" } } ], "announcement_id": "1430861", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T05:17:49Z", "company": "Medivir AB", "title": "MEDIVIR AB - BOKSLUTSKOMMUNIKÉ JANUARI - DECEMBER 2025", "category": "Bokslutskommuniké", "date": "2026-02-18", "language": "sv", "report_type": "year-end-report", "fiscal_year": 2025, "quarter": "q4", "period": "2025-q4", "report_key": "2025:q4", "release_url": "https://view.news.eu.nasdaq.com/view?id=be1459b14941a6653a5c9efa25c64be9c&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2025-q4\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2025-q4\\release.txt", "attachments": [ { "label": "Bokslutskommunike Januari - December 2025.pdf", "url": "https://attachment.news.eu.nasdaq.com/a6bc84f5b62b188ccd359ea7e7ad663e8", "final_url": "https://attachment.news.eu.nasdaq.com/a6bc84f5b62b188ccd359ea7e7ad663e8", "filename": "Bokslutskommunike_Januari_-_December_2025.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2025-q4\\Bokslutskommunike_Januari_-_December_2025.pdf", "content_type": "application/pdf", "size": 428752, "sha256": "3d68e4428a2c2763fe9d6dc1fe416b774313b24327641d1b998f072cd48e052c", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2025-q4\\Bokslutskommunike_Januari_-_December_2025.pdf", "filename": "Bokslutskommunike_Januari_-_December_2025.pdf", "extension": ".pdf", "size": 428752, "sha256": "3d68e4428a2c2763fe9d6dc1fe416b774313b24327641d1b998f072cd48e052c", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2025-q4\\extracted\\Bokslutskommunike_Januari_-_December_2025\\Bokslutskommunike_Januari_-_December_2025.txt", "text_chars": 49385, "metadata": { "page_count": 15, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2025-q4\\extracted\\Bokslutskommunike_Januari_-_December_2025\\Bokslutskommunike_Januari_-_December_2025.extraction.json" } } ], "announcement_id": "1420928", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T05:17:55Z", "company": "Medivir AB", "title": "MEDIVIR AB - DELÅRSRAPPORT JANUARI - SEPTEMBER 2025", "category": "Interimsrapport", "date": "2025-11-06", "language": "sv", "report_type": "interim-report", "fiscal_year": 2025, "quarter": "q3", "period": "2025-q3", "report_key": "2025:q3", "release_url": "https://view.news.eu.nasdaq.com/view?id=bd4fef8c76eadf1b61381b8c20c705dc6&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2025-q3\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2025-q3\\release.txt", "attachments": [ { "label": "Delarsrapport januari - september 2025.pdf", "url": "https://attachment.news.eu.nasdaq.com/a3f41bbec811b1e4cacd40fbd0de3046d", "final_url": "https://attachment.news.eu.nasdaq.com/a3f41bbec811b1e4cacd40fbd0de3046d", "filename": "Delarsrapport_januari_-_september_2025.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2025-q3\\Delarsrapport_januari_-_september_2025.pdf", "content_type": "application/pdf", "size": 400925, "sha256": "d4608f07c6fba84dcae2cb378f56d2f923c572bf49b8f946ef959b507b4cc469", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2025-q3\\Delarsrapport_januari_-_september_2025.pdf", "filename": "Delarsrapport_januari_-_september_2025.pdf", "extension": ".pdf", "size": 400925, "sha256": "d4608f07c6fba84dcae2cb378f56d2f923c572bf49b8f946ef959b507b4cc469", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2025-q3\\extracted\\Delarsrapport_januari_-_september_2025\\Delarsrapport_januari_-_september_2025.txt", "text_chars": 44580, "metadata": { "page_count": 14, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2025-q3\\extracted\\Delarsrapport_januari_-_september_2025\\Delarsrapport_januari_-_september_2025.extraction.json" } } ], "announcement_id": "1399100", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T05:18:01Z", "company": "Medivir AB", "title": "MEDIVIR AB - DELÅRSRAPPORT JANUARI - JUNI 2025", "category": "Halvårsrapport", "date": "2025-08-21", "language": "sv", "report_type": "interim-report", "fiscal_year": 2025, "quarter": "q2", "period": "2025-q2", "report_key": "2025:q2", "release_url": "https://view.news.eu.nasdaq.com/view?id=ba19197caab46a2052ab0e053259ac7c5&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2025-q2\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2025-q2\\release.txt", "attachments": [ { "label": "Delarsrapport januari - juni 2025 PDF.pdf", "url": "https://attachment.news.eu.nasdaq.com/a31d7ac7ca71f385510659620478ce505", "final_url": "https://attachment.news.eu.nasdaq.com/a31d7ac7ca71f385510659620478ce505", "filename": "Delarsrapport_januari_-_juni_2025_PDF.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2025-q2\\Delarsrapport_januari_-_juni_2025_PDF.pdf", "content_type": "application/pdf", "size": 401846, "sha256": "ce32f32bd24c53d425a8a67349f47494e5e3d068a486954bc2b5be8cbd47d5b0", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2025-q2\\Delarsrapport_januari_-_juni_2025_PDF.pdf", "filename": "Delarsrapport_januari_-_juni_2025_PDF.pdf", "extension": ".pdf", "size": 401846, "sha256": "ce32f32bd24c53d425a8a67349f47494e5e3d068a486954bc2b5be8cbd47d5b0", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2025-q2\\extracted\\Delarsrapport_januari_-_juni_2025_PDF\\Delarsrapport_januari_-_juni_2025_PDF.txt", "text_chars": 42791, "metadata": { "page_count": 15, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2025-q2\\extracted\\Delarsrapport_januari_-_juni_2025_PDF\\Delarsrapport_januari_-_juni_2025_PDF.extraction.json" } } ], "announcement_id": "1384460", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T05:18:07Z", "company": "Medivir AB", "title": "MEDIVIR AB - DELÅRSRAPPORT JANUARI - MARS 2025", "category": "Interimsrapport", "date": "2025-04-29", "language": "sv", "report_type": "interim-report", "fiscal_year": 2025, "quarter": "q1", "period": "2025-q1", "report_key": "2025:q1", "release_url": "https://view.news.eu.nasdaq.com/view?id=b959070c8eb709a38e914a474208ef1d4&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2025-q1\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2025-q1\\release.txt", "attachments": [ { "label": "Medivir AB delarsrapport januari - mars 2025.pdf", "url": "https://attachment.news.eu.nasdaq.com/a6186894ade1ef52c2d0b336532974793", "final_url": "https://attachment.news.eu.nasdaq.com/a6186894ade1ef52c2d0b336532974793", "filename": "Medivir_AB_delarsrapport_januari_-_mars_2025.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2025-q1\\Medivir_AB_delarsrapport_januari_-_mars_2025.pdf", "content_type": "application/pdf", "size": 405450, "sha256": "f82e84a6dbd577680726ee6005525bd55f603b63f695ab821b551917e0fcdb9e", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2025-q1\\Medivir_AB_delarsrapport_januari_-_mars_2025.pdf", "filename": "Medivir_AB_delarsrapport_januari_-_mars_2025.pdf", "extension": ".pdf", "size": 405450, "sha256": "f82e84a6dbd577680726ee6005525bd55f603b63f695ab821b551917e0fcdb9e", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2025-q1\\extracted\\Medivir_AB_delarsrapport_januari_-_mars_2025\\Medivir_AB_delarsrapport_januari_-_mars_2025.txt", "text_chars": 39833, "metadata": { "page_count": 14, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2025-q1\\extracted\\Medivir_AB_delarsrapport_januari_-_mars_2025\\Medivir_AB_delarsrapport_januari_-_mars_2025.extraction.json" } } ], "announcement_id": "1359069", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T05:18:17Z", "company": "Medivir AB", "title": "Medivirs årsredovisning för 2024 publiceras", "category": "Bokslut och Verksamhetsberättelse", "date": "2025-04-01", "language": "sv", "report_type": "annual-report", "fiscal_year": 2024, "quarter": "annual", "period": "2024-annual", "report_key": "2024:annual", "release_url": "https://view.news.eu.nasdaq.com/view?id=b9f72acd8b1cea60b0a69ede3b4588f47&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2024-annual\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2024-annual\\release.txt", "attachments": [ { "label": "Medivir Arsredovisning 2024.pdf", "url": "https://attachment.news.eu.nasdaq.com/a0fbfdffc2f8330eb01a78039a58d07b3", "final_url": "https://attachment.news.eu.nasdaq.com/a0fbfdffc2f8330eb01a78039a58d07b3", "filename": "Medivir_Arsredovisning_2024.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2024-annual\\Medivir_Arsredovisning_2024.pdf", "content_type": "application/pdf", "size": 2530249, "sha256": "7c0d8eff3bd18f592885e4621ffc4c1d1715ffa1b80b89e440dce61f09eb7e7f", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2024-annual\\Medivir_Arsredovisning_2024.pdf", "filename": "Medivir_Arsredovisning_2024.pdf", "extension": ".pdf", "size": 2530249, "sha256": "7c0d8eff3bd18f592885e4621ffc4c1d1715ffa1b80b89e440dce61f09eb7e7f", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2024-annual\\extracted\\Medivir_Arsredovisning_2024\\Medivir_Arsredovisning_2024.txt", "text_chars": 269216, "metadata": { "page_count": 70, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2024-annual\\extracted\\Medivir_Arsredovisning_2024\\Medivir_Arsredovisning_2024.extraction.json" } } ], "announcement_id": "1352885", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T05:18:19Z", "company": "Medivir AB", "title": "MEDIVIR AB - BOKSLUTSKOMMUNIKÈ JANUARI - DECEMBER 2024", "category": "Bokslutskommuniké", "date": "2025-02-18", "language": "sv", "report_type": "year-end-report", "fiscal_year": 2024, "quarter": "q4", "period": "2024-q4", "report_key": "2024:q4", "release_url": "https://view.news.eu.nasdaq.com/view?id=bcba24fb5e7d35f8d4582b53e6cd2850a&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2024-q4\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2024-q4\\release.txt", "attachments": [ { "label": "Medivir AB Bokslutskommunike januari - december 2024.pdf", "url": "https://attachment.news.eu.nasdaq.com/a7e9545c31bf311b618765d4259253629", "final_url": "https://attachment.news.eu.nasdaq.com/a7e9545c31bf311b618765d4259253629", "filename": "Medivir_AB_Bokslutskommunike_januari_-_december_2024.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2024-q4\\Medivir_AB_Bokslutskommunike_januari_-_december_2024.pdf", "content_type": "application/pdf", "size": 419991, "sha256": "f04470f88964f9cbca3e9cc7a75c5d428d7079487236380ec2cbd5fb95294fcf", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2024-q4\\Medivir_AB_Bokslutskommunike_januari_-_december_2024.pdf", "filename": "Medivir_AB_Bokslutskommunike_januari_-_december_2024.pdf", "extension": ".pdf", "size": 419991, "sha256": "f04470f88964f9cbca3e9cc7a75c5d428d7079487236380ec2cbd5fb95294fcf", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2024-q4\\extracted\\Medivir_AB_Bokslutskommunike_januari_-_decemb\\Medivir_AB_Bokslutskommunike_januari_-_december_20.txt", "text_chars": 46592, "metadata": { "page_count": 14, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2024-q4\\extracted\\Medivir_AB_Bokslutskommunike_januari_-_decemb\\Medivir_AB_Bokslutskommunike_januari_-_december_20.extraction.json" } } ], "announcement_id": "1343666", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T05:18:24Z", "company": "Medivir AB", "title": "MEDIVIR AB - DELÅRSRAPPORT JANUARI - SEPTEMBER 2024", "category": "Interimsrapport", "date": "2024-11-06", "language": "sv", "report_type": "interim-report", "fiscal_year": 2024, "quarter": "q3", "period": "2024-q3", "report_key": "2024:q3", "release_url": "https://view.news.eu.nasdaq.com/view?id=b33fa7d3b08181b3fb6d903c1aa445e4e&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2024-q3\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2024-q3\\release.txt", "attachments": [ { "label": "Medivir AB - Delarsrapport januari-september 2024.pdf", "url": "https://attachment.news.eu.nasdaq.com/a7cce4669387911c031222794cf78ddb7", "final_url": "https://attachment.news.eu.nasdaq.com/a7cce4669387911c031222794cf78ddb7", "filename": "Medivir_AB_-_Delarsrapport_januari-september_2024.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2024-q3\\Medivir_AB_-_Delarsrapport_januari-september_2024.pdf", "content_type": "application/pdf", "size": 417558, "sha256": "14e9f4f9498bba5d9288a1d17cd0be9c4597edd701442ef516bbe204f6c6d7a7", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2024-q3\\Medivir_AB_-_Delarsrapport_januari-september_2024.pdf", "filename": "Medivir_AB_-_Delarsrapport_januari-september_2024.pdf", "extension": ".pdf", "size": 417558, "sha256": "14e9f4f9498bba5d9288a1d17cd0be9c4597edd701442ef516bbe204f6c6d7a7", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2024-q3\\extracted\\Medivir_AB_-_Delarsrapport_januari-september_\\Medivir_AB_-_Delarsrapport_januari-september_2024.txt", "text_chars": 45749, "metadata": { "page_count": 14, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2024-q3\\extracted\\Medivir_AB_-_Delarsrapport_januari-september_\\Medivir_AB_-_Delarsrapport_januari-september_2024.extraction.json" } } ], "announcement_id": "1326030", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T05:18:28Z", "company": "Medivir AB", "title": "MEDIVIR AB - DELÅRSRAPPORT JANUARI - JUNI 2024", "category": "Halvårsrapport", "date": "2024-08-22", "language": "sv", "report_type": "interim-report", "fiscal_year": 2024, "quarter": "q2", "period": "2024-q2", "report_key": "2024:q2", "release_url": "https://view.news.eu.nasdaq.com/view?id=bd7d135b6dc8e1b83bf59e4293dbdd8f9&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2024-q2\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2024-q2\\release.txt", "attachments": [ { "label": "08217839.pdf", "url": "https://attachment.news.eu.nasdaq.com/ade03f0f56e5b99da8f3f0a9d4b4e244e", "final_url": "https://attachment.news.eu.nasdaq.com/ade03f0f56e5b99da8f3f0a9d4b4e244e", "filename": "08217839.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2024-q2\\08217839.pdf", "content_type": "application/pdf", "size": 401217, "sha256": "fed296ebd6e64219441a15ecbd08e67a9c25d2f821b30dbb96fd2188e2a12736", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2024-q2\\08217839.pdf", "filename": "08217839.pdf", "extension": ".pdf", "size": 401217, "sha256": "fed296ebd6e64219441a15ecbd08e67a9c25d2f821b30dbb96fd2188e2a12736", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2024-q2\\extracted\\08217839\\08217839.txt", "text_chars": 44806, "metadata": { "page_count": 14, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2024-q2\\extracted\\08217839\\08217839.extraction.json" } } ], "announcement_id": "1312197", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T05:18:33Z", "company": "Medivir AB", "title": "MEDIVIR AB - DELÅRSRAPPORT JANUARI - MARS 2024", "category": "Interimsrapport", "date": "2024-04-30", "language": "sv", "report_type": "interim-report", "fiscal_year": 2024, "quarter": "q1", "period": "2024-q1", "report_key": "2024:q1", "release_url": "https://view.news.eu.nasdaq.com/view?id=b68d64ab93e8d420aadd5fccabc8abad8&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2024-q1\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2024-q1\\release.txt", "attachments": [ { "label": "04290446.pdf", "url": "https://attachment.news.eu.nasdaq.com/af6b3d79d815b6a7f4f1c50d0c382b338", "final_url": "https://attachment.news.eu.nasdaq.com/af6b3d79d815b6a7f4f1c50d0c382b338", "filename": "04290446.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2024-q1\\04290446.pdf", "content_type": "application/pdf", "size": 387649, "sha256": "ad25b1725075150f7b54037108f997120fe91c8ab07b1f152abb5fe57b0af600", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2024-q1\\04290446.pdf", "filename": "04290446.pdf", "extension": ".pdf", "size": 387649, "sha256": "ad25b1725075150f7b54037108f997120fe91c8ab07b1f152abb5fe57b0af600", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2024-q1\\extracted\\04290446\\04290446.txt", "text_chars": 41422, "metadata": { "page_count": 13, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2024-q1\\extracted\\04290446\\04290446.extraction.json" } } ], "announcement_id": "1292026", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T05:18:48Z", "company": "Medivir AB", "title": "Medivirs årsredovisning för 2023 publiceras", "category": "Bokslut och Verksamhetsberättelse", "date": "2024-04-04", "language": "sv", "report_type": "annual-report", "fiscal_year": 2023, "quarter": "annual", "period": "2023-annual", "report_key": "2023:annual", "release_url": "https://view.news.eu.nasdaq.com/view?id=b2b5d5a3509869dead2274c9dc8799d91&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2023-annual\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2023-annual\\release.txt", "attachments": [ { "label": "PR 4 april AR SV.pdf", "url": "https://attachment.news.eu.nasdaq.com/a39650be1c08fe773c42587bded88f7ef", "final_url": "https://attachment.news.eu.nasdaq.com/a39650be1c08fe773c42587bded88f7ef", "filename": "PR_4_april_AR_SV.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2023-annual\\PR_4_april_AR_SV.pdf", "content_type": "application/pdf", "size": 144426, "sha256": "57d12f169e7526b5423650aa143d075a16ded077e32a9c00454a40de21e7e724", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2023-annual\\PR_4_april_AR_SV.pdf", "filename": "PR_4_april_AR_SV.pdf", "extension": ".pdf", "size": 144426, "sha256": "57d12f169e7526b5423650aa143d075a16ded077e32a9c00454a40de21e7e724", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2023-annual\\extracted\\PR_4_april_AR_SV\\PR_4_april_AR_SV.txt", "text_chars": 2563, "metadata": { "page_count": 1, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2023-annual\\extracted\\PR_4_april_AR_SV\\PR_4_april_AR_SV.extraction.json" } }, { "label": "04046626.pdf", "url": "https://attachment.news.eu.nasdaq.com/a917909479c43fb4f526ecccae0d35a06", "final_url": "https://attachment.news.eu.nasdaq.com/a917909479c43fb4f526ecccae0d35a06", "filename": "04046626.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2023-annual\\04046626.pdf", "content_type": "application/pdf", "size": 3399172, "sha256": "cdd18d152b3acad5b14f195ea138e9ec96da8575f672ce0280f0dfeb5c437de1", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2023-annual\\04046626.pdf", "filename": "04046626.pdf", "extension": ".pdf", "size": 3399172, "sha256": "cdd18d152b3acad5b14f195ea138e9ec96da8575f672ce0280f0dfeb5c437de1", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2023-annual\\extracted\\04046626\\04046626.txt", "text_chars": 266804, "metadata": { "page_count": 69, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2023-annual\\extracted\\04046626\\04046626.extraction.json" } } ], "announcement_id": "1285763", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T05:18:50Z", "company": "Medivir AB", "title": "MEDIVIR AB - BOKSLUTSKOMMUNIKÉ JANUARI - DECEMBER 2023", "category": "Bokslutskommuniké", "date": "2024-02-15", "language": "sv", "report_type": "year-end-report", "fiscal_year": 2023, "quarter": "q4", "period": "2023-q4", "report_key": "2023:q4", "release_url": "https://view.news.eu.nasdaq.com/view?id=b00b8bfc43e0056704857fedd1ad9d279&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2023-q4\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2023-q4\\release.txt", "attachments": [ { "label": "02148740.pdf", "url": "https://attachment.news.eu.nasdaq.com/a7f04caac4a581322fa52c39da0521b79", "final_url": "https://attachment.news.eu.nasdaq.com/a7f04caac4a581322fa52c39da0521b79", "filename": "02148740.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2023-q4\\02148740.pdf", "content_type": "application/pdf", "size": 376138, "sha256": "c16918211d650cdd7f273540b788109b0e448f353e000aa64f6f1acd0a0d458c", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2023-q4\\02148740.pdf", "filename": "02148740.pdf", "extension": ".pdf", "size": 376138, "sha256": "c16918211d650cdd7f273540b788109b0e448f353e000aa64f6f1acd0a0d458c", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2023-q4\\extracted\\02148740\\02148740.txt", "text_chars": 45994, "metadata": { "page_count": 13, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2023-q4\\extracted\\02148740\\02148740.extraction.json" } } ], "announcement_id": "1275017", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T05:18:55Z", "company": "Medivir AB", "title": "MEDIVIR AB - DELÅRSRAPPORT JANUARI - SEPTEMBER 2023", "category": "Interimsrapport", "date": "2023-10-27", "language": "sv", "report_type": "interim-report", "fiscal_year": 2023, "quarter": "q3", "period": "2023-q3", "report_key": "2023:q3", "release_url": "https://view.news.eu.nasdaq.com/view?id=bf98c97348192561a0113de66f7884e74&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2023-q3\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2023-q3\\release.txt", "attachments": [ { "label": "10263068.pdf", "url": "https://attachment.news.eu.nasdaq.com/a73a46fc5e8c90b79385dc64ffbfd556b", "final_url": "https://attachment.news.eu.nasdaq.com/a73a46fc5e8c90b79385dc64ffbfd556b", "filename": "10263068.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2023-q3\\10263068.pdf", "content_type": "application/pdf", "size": 410076, "sha256": "c1af975248a2f6688b5ac7a7a8b13e3a676bf2ef07778fc6a085d7eeb664824b", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2023-q3\\10263068.pdf", "filename": "10263068.pdf", "extension": ".pdf", "size": 410076, "sha256": "c1af975248a2f6688b5ac7a7a8b13e3a676bf2ef07778fc6a085d7eeb664824b", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2023-q3\\extracted\\10263068\\10263068.txt", "text_chars": 45912, "metadata": { "page_count": 14, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2023-q3\\extracted\\10263068\\10263068.extraction.json" } } ], "announcement_id": "1255486", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T05:19:00Z", "company": "Medivir AB", "title": "MEDIVIR AB - DELÅRSRAPPORT JANUARI - JUNI 2023", "category": "Halvårsrapport", "date": "2023-08-18", "language": "sv", "report_type": "interim-report", "fiscal_year": 2023, "quarter": "q2", "period": "2023-q2", "report_key": "2023:q2", "release_url": "https://view.news.eu.nasdaq.com/view?id=bdee061509018ccfab933b391601c448c&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2023-q2\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2023-q2\\release.txt", "attachments": [ { "label": "08178120.pdf", "url": "https://attachment.news.eu.nasdaq.com/aeb29450876d3df4780432f1a4e354c7a", "final_url": "https://attachment.news.eu.nasdaq.com/aeb29450876d3df4780432f1a4e354c7a", "filename": "08178120.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2023-q2\\08178120.pdf", "content_type": "application/pdf", "size": 361298, "sha256": "ceb4c39d3d1d334b258675ce7885b5c8ff296707a5eed58c13c8064c971f2c23", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2023-q2\\08178120.pdf", "filename": "08178120.pdf", "extension": ".pdf", "size": 361298, "sha256": "ceb4c39d3d1d334b258675ce7885b5c8ff296707a5eed58c13c8064c971f2c23", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2023-q2\\extracted\\08178120\\08178120.txt", "text_chars": 39791, "metadata": { "page_count": 13, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2023-q2\\extracted\\08178120\\08178120.extraction.json" } } ], "announcement_id": "1243236", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T05:19:05Z", "company": "Medivir AB", "title": "MEDIVIR AB - DELÅRSRAPPORT JANUARI - MARS 2023", "category": "Interimsrapport", "date": "2023-04-27", "language": "sv", "report_type": "interim-report", "fiscal_year": 2023, "quarter": "q1", "period": "2023-q1", "report_key": "2023:q1", "release_url": "https://view.news.eu.nasdaq.com/view?id=b189c198e883bde192ea982c79a96d50b&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2023-q1\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2023-q1\\release.txt", "attachments": [ { "label": "04267191.pdf", "url": "https://attachment.news.eu.nasdaq.com/a3fa0a1fc78ee14d44209b8e377dfed58", "final_url": "https://attachment.news.eu.nasdaq.com/a3fa0a1fc78ee14d44209b8e377dfed58", "filename": "04267191.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2023-q1\\04267191.pdf", "content_type": "application/pdf", "size": 349115, "sha256": "75b24e8f1e597102f92b59ec662788b75f3eac2bb3af8aed161c0312d5ad70a8", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2023-q1\\04267191.pdf", "filename": "04267191.pdf", "extension": ".pdf", "size": 349115, "sha256": "75b24e8f1e597102f92b59ec662788b75f3eac2bb3af8aed161c0312d5ad70a8", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2023-q1\\extracted\\04267191\\04267191.txt", "text_chars": 34181, "metadata": { "page_count": 12, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\medivir\\nasdaq-reports\\reports\\2023-q1\\extracted\\04267191\\04267191.extraction.json" } } ], "announcement_id": "1223135", "status": "retrieved" } ], "attempts": [ { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Medivir&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 0, "pagination": "row-offset", "query_text": "Medivir", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "865ab1d4b9173b7ed06be43b6d81bc8309e6654b20c1c0db5e331a65897ea151" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Medivir&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=100&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 100, "pagination": "row-offset", "query_text": "Medivir", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "afe14bacd606dd51d017004397493b3dd7fc48851d244477513f1b0d381def37" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Medivir&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=200&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 200, "pagination": "row-offset", "query_text": "Medivir", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "ebbe12be5a711f436ef255abb36699024beb743d339ca1652292d31f798ec496" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Medivir&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=300&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 300, "pagination": "row-offset", "query_text": "Medivir", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "5c80937b6f323f5a8b8bece13ae83dc48ea75f83368e6c74dfdb42a7bfd86702" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Medivir&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=400&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 400, "pagination": "row-offset", "query_text": "Medivir", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "aafb70f9be856acc4edf3b23a712d3670c109a2c5bd15bab6189967cc4ff0d21" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Medivir&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=500&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 500, "pagination": "row-offset", "query_text": "Medivir", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "868e6660f6c2dd52e807f0abd68e3e2998c683cd638b94de4a27b29672ecadeb" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Medivir&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "sv", "start": 0, "pagination": "row-offset", "query_text": "Medivir", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 24, "new_rows": 24, "total_count": null, "from_cache": false, "body_sha256": "6dc0e1b5069c23d4f341f046f23c291278e3dd39539b6be4d87cc7e26afa4275" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Medivir&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=24&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "sv", "start": 24, "pagination": "row-offset", "query_text": "Medivir", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 0, "new_rows": 0, "total_count": null, "from_cache": false, "body_sha256": "bc7b6dde5e6354d420e38e313fa65c8d0ab272a53938bc1be8c10df814ff5c17" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Medivir&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "en", "start": 0, "pagination": "row-offset", "query_text": "Medivir", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "3dbe2409834466950a495121529d339149cf4a7fdad0df39defc77f48d091dc9" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Medivir&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=100&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "en", "start": 100, "pagination": "row-offset", "query_text": "Medivir", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "14c7b89b479da34904e4418a53d6d95ae9f4561913504941b5e68433f18035e3" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Medivir&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=200&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "en", "start": 200, "pagination": "row-offset", "query_text": "Medivir", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "445ae52be0b185908be1c45fc169edeea431aa8d242e8f1a2c2a77e2efa860d1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Medivir&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=300&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "en", "start": 300, "pagination": "row-offset", "query_text": "Medivir", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "5dd1550b03c0cc49a13c0eee012bd8e7e496a54d42780f1038d5f3172358debc" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Medivir&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=400&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "en", "start": 400, "pagination": "row-offset", "query_text": "Medivir", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "7167afe746e7a9ef1344354c9b3a78f70f4e569f282a09667858bb56ccbd2e37" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Medivir&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=500&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "en", "start": 500, "pagination": "row-offset", "query_text": "Medivir", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "7de35c7d5dfd97ab1dc06f37ee9c066f0449c241e8110ae021cf426f6eb7a08c" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Medivir&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "en", "start": 0, "pagination": "row-offset", "query_text": "Medivir", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 13, "new_rows": 13, "total_count": null, "from_cache": false, "body_sha256": "addd5b83c3a1db490dd231b1e77856f84f1acf1079ea34bbae1e4d0dec6fa126" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Medivir&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=13&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "en", "start": 13, "pagination": "row-offset", "query_text": "Medivir", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 0, "new_rows": 0, "total_count": null, "from_cache": false, "body_sha256": "10c6188c6d2d9548fcf366a5fa274b07aa38c0b8bd7c74db406b662cecdb1435" } ], "identity": { "slug": "", "instrument_id": "TX219", "resolved_url": "https://www.nasdaq.com/european-market-activity/shares/mvir?id=TX219" }, "transport": "ordinary-http", "browser_used": false, "query_text": "Medivir", "retrieved_at": "2026-08-07T05:19:05Z" }